Abstract
Glutathione S-transferase P1 (GSTP1), an enzyme involved in detoxification process, is frequently inactivated in prostate cancer due to epigenetic modifications. Through in silico analysis, we identified a subset of microRNAs (miRNAs) that are putative targets in regulating GSTP1. miRNAs are small endogenous non-coding RNA that are critical regulators of various physiologic and pathologic processes, and their level of expression may play a precise role in the early diagnosis and prognosis of cancer. These small molecules have been detected in a wide variety of human biological specimens including blood, serum, urine, ejaculate, and tissues, which could be utilized as clinically useful biomarker in early detection and prognosis of prostate cancer. The chapter summarizes the current knowledge about miRNA involved in GSTP1 regulation in prostate cancer and their potential as useful biomarkers of the disease for early detection and prognosis, along with challenges and limitations in this development.
| Original language | English |
|---|---|
| Pages (from-to) | 79-88 |
| Number of pages | 10 |
| Journal | Current Pharmacology Reports |
| Volume | 1 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Epigenetics
- GSTP1
- miRNA
- Oxidative DNA damage
- Prostate cancer
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver